DOI: 10.1016/s1473-3099(06)70689-2. Anti-infective research and development

Anti-infective research and development—problems, challenges, and solutions

10.1016/s1473-3099(06)70689-2

Crossref journal-article

Elsevier BV

The Lancet Infectious Diseases (78)

Bibliography

Bradley, J. S., Guidos, R., Baragona, S., Bartlett, J. G., Rubinstein, E., Zhanel, G. G., Tino, M. D., Pompliano, D. L., Tally, F., Tipirneni, P., Tillotson, G. S., Powers, J. H., & Tillotson, G. S. (2007). Anti-infective research and developmentâproblems, challenges, and solutions. The Lancet Infectious Diseases, 7(1), 68â78.

Authors 13

John S Bradley (first)
Robert Guidos (additional)
Steve Baragona (additional)
John G Bartlett (additional)
Ethan Rubinstein (additional)
George G Zhanel (additional)
Michael D Tino (additional)
David L Pompliano (additional)
Frank Tally (additional)
Praveen Tipirneni (additional)
Glenn S Tillotson (additional)
John H Powers (additional)
Glenn S Tillotson (additional)

References 25 Referenced 69

10.1086/420937 / Clin Infect Dis / Trends in antimicrobial drug development: implications for the future by Spellberg (2004)
{'year': '2004', 'series-title': 'Bad bugs, no drugs: as antibiotic discovery stagnates…a public health crisis brews', 'key': '10.1016/S1473-3099(06)70689-2_bib2'} / Bad bugs, no drugs: as antibiotic discovery stagnates…a public health crisis brews (2004)
10.1086/499819 / Clin Infect Dis / Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America by Talbot (2006)
10.1097/01.CCM.0000217961.75225.E9 / Crit Care Med / Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock by Kumar (2006)
10.1097/01.CCM.0000055381.70829.94 / Crit Care Med / Treatment of ventilator-associated pneumonia: get it right from the start by Kollef (2003)
10.1086/496986 / Clin Infect Dis / Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec by Pepin (2005)
10.1086/505900 / Infect Control Hosp Epidemiol / Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide by Richet (2006)
10.3121/cmr.4.2.138 / Clin Med Res / The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature by Falagas (2006)
10.1001/jama.290.19.2588 / JAMA / Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial by Chastre (2003)
10.1056/NEJMoa054493 / N Engl J Med / Single-dose azithromycin for the treatment of cholera in adults by Saha (2006)
10.7326/0003-4819-109-8-619 / Ann Intern Med / Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy by Chambers (1988)
10.1016/j.amjmed.2005.02.005 / Am J Med / Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis by Katchman (2005)
{'key': '10.1016/S1473-3099(06)70689-2_bib16', 'series-title': 'The Sanford guide to antimicrobial therapy', 'first-page': '25', 'author': 'Gilbert', 'year': '2005'} / The Sanford guide to antimicrobial therapy by Gilbert (2005)
{'year': '2004', 'series-title': 'Priority medicines for Europe and the world', 'key': '10.1016/S1473-3099(06)70689-2_bib17'} / Priority medicines for Europe and the world (2004)
{'volume': 'Volume 8', 'year': '2006', 'key': '10.1016/S1473-3099(06)70689-2_bib18'} (2006)
{'author': 'Lewis', 'key': '10.1016/S1473-3099(06)70689-2_bib19'} by Lewis
{'issue': 'suppl 1', 'key': '10.1016/S1473-3099(06)70689-2_bib20', 'first-page': '19', 'article-title': 'Clinical significance of pneumococcal resistance and factors influencing outcomes', 'volume': '4', 'author': 'Bishai', 'year': '2005', 'journal-title': 'Treat Respir Med'} / Treat Respir Med / Clinical significance of pneumococcal resistance and factors influencing outcomes by Bishai (2005)
10.1086/380126 / Clin Infect Dis / The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative by Nuermberger (2004)
10.1592/phco.2005.25.12part2.109S / Pharmacotherapy / Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials by Powers (2005)
10.3201/eid1202.050078 / Emerg Infect Dis / Antimicrobial drug resistance, regulation, and research by Metlay (2006)
10.1016/j.ijantimicag.2004.03.008 / Int J Antimicrob Agents / A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae by Rzeszutek (2004)
10.1056/NEJMoa020191 / N Engl J Med / Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis by Herbrecht (2002)
10.1056/NEJMp058317 / N Engl J Med / Adopting orphan drugs—two dozen years of treating rare diseases by Haffner (2006)
10.1056/NEJMp068228 / N Engl J Med / Protecting the Health of the Public—Institute of Medicine Recommendations on Drug Safety by Psaty (2006)
10.7326/0003-4819-125-7-199610010-00011 / Ann Intern Med / Surrogate end points in clinical trials: are we being misled? by Fleming (1996)

Dates

Type	When
Created	18 years, 8 months ago (Dec. 19, 2006, 9:32 a.m.)
Deposited	6 years, 7 months ago (Jan. 10, 2019, 1:57 p.m.)
Indexed	2 months, 2 weeks ago (June 17, 2025, 6:48 a.m.)
Issued	18 years, 8 months ago (Jan. 1, 2007)
Published	18 years, 8 months ago (Jan. 1, 2007)
Published Print	18 years, 8 months ago (Jan. 1, 2007)

Funders 0

None

BibTeX

@article{Bradley_2007, title={Anti-infective research and development—problems, challenges, and solutions}, volume={7}, ISSN={1473-3099}, url={http://dx.doi.org/10.1016/s1473-3099(06)70689-2}, DOI={10.1016/s1473-3099(06)70689-2}, number={1}, journal={The Lancet Infectious Diseases}, publisher={Elsevier BV}, author={Bradley, John S and Guidos, Robert and Baragona, Steve and Bartlett, John G and Rubinstein, Ethan and Zhanel, George G and Tino, Michael D and Pompliano, David L and Tally, Frank and Tipirneni, Praveen and Tillotson, Glenn S and Powers, John H and Tillotson, Glenn S}, year={2007}, month=jan, pages={68–78} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        17
      ]
    ],
    "date-time": "2025-06-17T10:48:59Z",
    "timestamp": 1750157339092
  },
  "reference-count": 25,
  "publisher": "Elsevier BV",
  "issue": "1",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2007,
            1,
            1
          ]
        ],
        "date-time": "2007-01-01T00:00:00Z",
        "timestamp": 1167609600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        1
      ]
    ]
  },
  "DOI": "10.1016/s1473-3099(06)70689-2",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2006,
        12,
        19
      ]
    ],
    "date-time": "2006-12-19T14:32:17Z",
    "timestamp": 1166538737000
  },
  "page": "68-78",
  "source": "Crossref",
  "is-referenced-by-count": 69,
  "title": "Anti-infective research and development\u2014problems, challenges, and solutions",
  "prefix": "10.1016",
  "volume": "7",
  "author": [
    {
      "given": "John S",
      "family": "Bradley",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Robert",
      "family": "Guidos",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Steve",
      "family": "Baragona",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "John G",
      "family": "Bartlett",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Ethan",
      "family": "Rubinstein",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "George G",
      "family": "Zhanel",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Michael D",
      "family": "Tino",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "David L",
      "family": "Pompliano",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Frank",
      "family": "Tally",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Praveen",
      "family": "Tipirneni",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Glenn S",
      "family": "Tillotson",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "John H",
      "family": "Powers",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Glenn S",
      "family": "Tillotson",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "1279",
      "DOI": "10.1086/420937",
      "article-title": "Trends in antimicrobial drug development: implications for the future",
      "volume": "38",
      "author": "Spellberg",
      "year": "2004",
      "journal-title": "Clin Infect Dis"
    },
    {
      "year": "2004",
      "series-title": "Bad bugs, no drugs: as antibiotic discovery stagnates\u2026a public health crisis brews",
      "key": "10.1016/S1473-3099(06)70689-2_bib2"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "657",
      "DOI": "10.1086/499819",
      "article-title": "Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America",
      "volume": "42",
      "author": "Talbot",
      "year": "2006",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "1589",
      "DOI": "10.1097/01.CCM.0000217961.75225.E9",
      "article-title": "Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock",
      "volume": "34",
      "author": "Kumar",
      "year": "2006",
      "journal-title": "Crit Care Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "969",
      "DOI": "10.1097/01.CCM.0000055381.70829.94",
      "article-title": "Treatment of ventilator-associated pneumonia: get it right from the start",
      "volume": "31",
      "author": "Kollef",
      "year": "2003",
      "journal-title": "Crit Care Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "1254",
      "DOI": "10.1086/496986",
      "article-title": "Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec",
      "volume": "41",
      "author": "Pepin",
      "year": "2005",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "645",
      "DOI": "10.1086/505900",
      "article-title": "Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide",
      "volume": "27",
      "author": "Richet",
      "year": "2006",
      "journal-title": "Infect Control Hosp Epidemiol"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "138",
      "DOI": "10.3121/cmr.4.2.138",
      "article-title": "The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature",
      "volume": "4",
      "author": "Falagas",
      "year": "2006",
      "journal-title": "Clin Med Res"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "2588",
      "DOI": "10.1001/jama.290.19.2588",
      "article-title": "Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial",
      "volume": "290",
      "author": "Chastre",
      "year": "2003",
      "journal-title": "JAMA"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "2452",
      "DOI": "10.1056/NEJMoa054493",
      "article-title": "Single-dose azithromycin for the treatment of cholera in adults",
      "volume": "354",
      "author": "Saha",
      "year": "2006",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "619",
      "DOI": "10.7326/0003-4819-109-8-619",
      "article-title": "Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy",
      "volume": "109",
      "author": "Chambers",
      "year": "1988",
      "journal-title": "Ann Intern Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "1196",
      "DOI": "10.1016/j.amjmed.2005.02.005",
      "article-title": "Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis",
      "volume": "118",
      "author": "Katchman",
      "year": "2005",
      "journal-title": "Am J Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib16",
      "series-title": "The Sanford guide to antimicrobial therapy",
      "first-page": "25",
      "author": "Gilbert",
      "year": "2005"
    },
    {
      "year": "2004",
      "series-title": "Priority medicines for Europe and the world",
      "key": "10.1016/S1473-3099(06)70689-2_bib17"
    },
    {
      "volume": "Volume 8",
      "year": "2006",
      "key": "10.1016/S1473-3099(06)70689-2_bib18"
    },
    {
      "author": "Lewis",
      "key": "10.1016/S1473-3099(06)70689-2_bib19"
    },
    {
      "issue": "suppl 1",
      "key": "10.1016/S1473-3099(06)70689-2_bib20",
      "first-page": "19",
      "article-title": "Clinical significance of pneumococcal resistance and factors influencing outcomes",
      "volume": "4",
      "author": "Bishai",
      "year": "2005",
      "journal-title": "Treat Respir Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "DOI": "10.1086/380126",
      "article-title": "The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative",
      "volume": "38",
      "author": "Nuermberger",
      "year": "2004",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "109S",
      "DOI": "10.1592/phco.2005.25.12part2.109S",
      "article-title": "Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials",
      "volume": "25",
      "author": "Powers",
      "year": "2005",
      "journal-title": "Pharmacotherapy"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "DOI": "10.3201/eid1202.050078",
      "article-title": "Antimicrobial drug resistance, regulation, and research",
      "volume": "12",
      "author": "Metlay",
      "year": "2006",
      "journal-title": "Emerg Infect Dis"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "DOI": "10.1016/j.ijantimicag.2004.03.008",
      "article-title": "A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae",
      "volume": "24",
      "author": "Rzeszutek",
      "year": "2004",
      "journal-title": "Int J Antimicrob Agents"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "408",
      "DOI": "10.1056/NEJMoa020191",
      "article-title": "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis",
      "volume": "347",
      "author": "Herbrecht",
      "year": "2002",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "445",
      "DOI": "10.1056/NEJMp058317",
      "article-title": "Adopting orphan drugs\u2014two dozen years of treating rare diseases",
      "volume": "354",
      "author": "Haffner",
      "year": "2006",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "1753",
      "DOI": "10.1056/NEJMp068228",
      "article-title": "Protecting the Health of the Public\u2014Institute of Medicine Recommendations on Drug Safety",
      "volume": "355",
      "author": "Psaty",
      "year": "2006",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1473-3099(06)70689-2_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "605",
      "DOI": "10.7326/0003-4819-125-7-199610010-00011",
      "article-title": "Surrogate end points in clinical trials: are we being misled?",
      "volume": "125",
      "author": "Fleming",
      "year": "1996",
      "journal-title": "Ann Intern Med"
    }
  ],
  "container-title": "The Lancet Infectious Diseases",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1473309906706892?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1473309906706892?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        1,
        10
      ]
    ],
    "date-time": "2019-01-10T18:57:02Z",
    "timestamp": 1547146622000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1473309906706892"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2007,
        1
      ]
    ]
  },
  "references-count": 25,
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2007,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "S1473309906706892"
  ],
  "URL": "http://dx.doi.org/10.1016/S1473-3099(06)70689-2",
  "relation": {},
  "ISSN": [
    "1473-3099"
  ],
  "subject": [],
  "container-title-short": "The Lancet Infectious Diseases",
  "published": {
    "date-parts": [
      [
        2007,
        1
      ]
    ]
  }
}